Pioneering the next generation of treatment solutions
We support innovation across the continuum of care, to help to develop new technologies, treatments and vaccines.
A groundbreaking partnership between countries, health organizations and companies worldwide—including Johnson & Johnson—hopes to find the most promising vaccines to help protect people from the virus.
Two decades after leaving India, Anil Koul has returned to helm its Institute of Microbial Technology. For Dengue Awareness Month, we caught up with him to learn how he’s hoping to combat this tropical scourge and another disease that kills over a million worldwide.
Ground breaking therapy offers hope for people with Multi-Drug Resistant Tuberculosis (MDR-TB)
Caring & giving
Caring & giving
For the fifth anniversary of the London Declaration, we’re sharing the steps the company has taken to fulfill its promise to fight neglected tropical diseases—including the development of a chewable form of mebendazole.
More from Johnson & Johnson
With a unique disposable camera the size of a pinkie finger, Eric Buehlmann and his team pioneered a better—and easier—way for doctors to perform back procedures.
For the last 10 years, Johnson & Johnson Innovation has been on a mission to accelerate early-stage innovation aimed at advancing healthcare. As digital technology external innovation lead, Varun Ramdevan looks for the best ideas—and helps make them a reality.
The goal of precision medicine is to develop individualized treatments based on a patient’s genetic profile. Here’s how Johnson & Johnson is harnessing this cutting-edge field of tailor-made medicine.